Effect of Subnormothermic Machine Perfusion on the Preservation of Vascularized Composite Allografts After Prolonged Warm Ischemia.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
09 May 2024
09 May 2024
Historique:
medline:
10
5
2024
pubmed:
10
5
2024
entrez:
9
5
2024
Statut:
aheadofprint
Résumé
Warm ischemia time (WIT) and ischemia-reperfusion injury are limiting factors for vascularized composite allograft (VCA) transplantation. Subnormothermic machine perfusion (SNMP) has demonstrated the potential to extend WIT in organ transplantation. This study evaluates the effect of SNMP on VCA viability after prolonged WIT. Rat hindlimbs underwent WIT for 30, 45, 60, 120, 150, or 210 min, followed by 3-h SNMP. Monitoring of perfusion parameters and outflow determined the maximum WIT compatible with limb viability after SNMP. Thereafter, 2 groups were assessed: a control group with inbred transplantation (Txp) after 120 min of WIT and an experimental group that underwent WIT + SNMP + Txp. Graft appearance, blood gas, cytokine levels, and histology were assessed for 21 d. Based on potassium levels, the limit of WIT compatible with limb viability after SNMP is 120 min. Before this limit, SNMP reduces potassium and lactate levels of WIT grafts to the same level as fresh grafts. In vivo, the control group presented 80% graft necrosis, whereas the experimental group showed no necrosis, had better healing (P = 0.0004), and reduced histological muscle injury (P = 0.012). Results of blood analysis revealed lower lactate, potassium levels, and calcium levels (P = 0.048) in the experimental group. Both groups presented an increase in interleukin (IL)-10 and IL-1b/IL-1F2 with a return to baseline after 7 to 14 d. Our study establishes the limit of WIT compatible with VCA viability and demonstrates the effectiveness of SNMP in restoring a graft after WIT ex vivo and in vivo, locally and systemically.
Sections du résumé
BACKGROUND
BACKGROUND
Warm ischemia time (WIT) and ischemia-reperfusion injury are limiting factors for vascularized composite allograft (VCA) transplantation. Subnormothermic machine perfusion (SNMP) has demonstrated the potential to extend WIT in organ transplantation. This study evaluates the effect of SNMP on VCA viability after prolonged WIT.
METHODS
METHODS
Rat hindlimbs underwent WIT for 30, 45, 60, 120, 150, or 210 min, followed by 3-h SNMP. Monitoring of perfusion parameters and outflow determined the maximum WIT compatible with limb viability after SNMP. Thereafter, 2 groups were assessed: a control group with inbred transplantation (Txp) after 120 min of WIT and an experimental group that underwent WIT + SNMP + Txp. Graft appearance, blood gas, cytokine levels, and histology were assessed for 21 d.
RESULTS
RESULTS
Based on potassium levels, the limit of WIT compatible with limb viability after SNMP is 120 min. Before this limit, SNMP reduces potassium and lactate levels of WIT grafts to the same level as fresh grafts. In vivo, the control group presented 80% graft necrosis, whereas the experimental group showed no necrosis, had better healing (P = 0.0004), and reduced histological muscle injury (P = 0.012). Results of blood analysis revealed lower lactate, potassium levels, and calcium levels (P = 0.048) in the experimental group. Both groups presented an increase in interleukin (IL)-10 and IL-1b/IL-1F2 with a return to baseline after 7 to 14 d.
CONCLUSIONS
CONCLUSIONS
Our study establishes the limit of WIT compatible with VCA viability and demonstrates the effectiveness of SNMP in restoring a graft after WIT ex vivo and in vivo, locally and systemically.
Identifiants
pubmed: 38722685
doi: 10.1097/TP.0000000000005035
pii: 00007890-990000000-00746
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Diaz-Siso JR, Bueno EM, Sisk GC, et al. Vascularized composite tissue allotransplantation—state of the art. Clin Transplant. 2013;27:330–337.
He J, Khan UZ, Qing L, et al. Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: clinical experience and experimental implications. Front Immunol. 2022;13:998952.
Datta N, Devaney SG, Busuttil RW, et al. Prolonged cold ischemia time results in local and remote organ dysfunction in a murine model of vascularized composite transplantation. Am J Transplant. 2017;17:2572–2579.
Pradka SP, Ong YS, Zhang Y, et al. Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model. Transplant Proc. 2009;41:531–536.
Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87:401–411.
Wainright JL, Wholley CL, Rosendale J, et al. VCA deceased donors in the United States. Transplantation. 2019;103:990–997.
Knijff LWD, van Kooten C, Ploeg RJ. The effect of hypothermic machine perfusion to ameliorate ischemia-reperfusion injury in donor organs. Front Immunol. 2022;13:848352.
López-Martínez S, Simón C, Santamaria X. Normothermic machine perfusion systems: where do we go from here? Transplantation. 2024;108:22–44.
Werner NL, Alghanem F, Rakestraw SL, et al. Ex situ perfusion of human limb allografts for 24 hours. Transplantation. 2017;101:e68–e74.
Goutard M, de Vries RJ, Tawa P, et al. Exceeding the limits of static cold storage in limb transplantation using subnormothermic machine perfusion. J Reconstr Microsurg. 2023;39:350–360.
Rezaei M, Ordenana C, Figueroa BA, et al. Ex vivo normothermic perfusion of human upper limbs. Transplantation. 2022;106:1638–1646.
Goutard M, Randolph MA, Taveau CB, et al. Partial heterotopic hindlimb transplantation model in rats. J Vis Exp. 2021;172.
Sucher R, Oberhuber R, Margreiter C, et al. Orthotopic hind-limb transplantation in rats. J Vis Exp. 2010;41.
Kruit AS, Brouwers K, van Midden D, et al. Successful 18-h acellular extracorporeal perfusion and replantation of porcine limbs—histology versus nerve stimulation. Transpl Int. 2021;34:365–375.
Kruit AS, van Midden D, Schreinemachers MC, et al. Rectus abdominis flap replantation after 18 h hypothermic extracorporeal perfusion—a porcine model. J Clin Med. 2021;10:3858.
Charlès L, Agius T, Filz von Reiterdank I, et al. Modified tail vein and penile vein puncture for blood sampling in the rat model. J Vis Exp. 2023;196.
De Carlis L, De Carlis R, Lauterio A, et al. Sequential use of normothermic regional perfusion and hypothermic machine perfusion in donation after cardiac death liver transplantation with extended warm ischemia time. Transplantation. 2016;100:e101–e102.
van Leeuwen OB, Bodewes SB, Porte RJ, et al. Excellent long-term outcome after sequential hypothermic and normothermic machine perfusion challenges the importance of functional donor warm ischemia time in DCD liver transplantation. J Hepatol. 2023;79:e244–e245.
Zulpaite R, Miknevicius P, Leber B, et al. Kidney machine perfusion: therapeutic potential. Front Med (Lausanne). 2021;8:808719.
Kataria A, Magoon S, Makkar B, et al. Machine perfusion in kidney transplantation. Curr Opin Organ Transplant. 2019;24:378–384.
von Horn C, Zlatev H, Kaths M, et al. Controlled oxygenated rewarming compensates for cold storage-induced dysfunction in kidney grafts. Transplantation. 2022;106:973–978.
Domingo-Pech J, Garriga JM, Toran N, et al. Preservation of the amputated canine hind limb by extracorporeal perfusion. Int Orthop. 1991;15:289–291.
Araki J, Sakai H, Takeuchi D, et al. Normothermic preservation of the rat hind limb with artificial oxygen-carrying hemoglobin vesicles. Transplantation. 2015;99:687–692.
Ozer K, Rojas-Pena A, Mendias CL, et al. Ex situ limb perfusion system to extend vascularized composite tissue allograft survival in swine. Transplantation. 2015;99:2095–2101.
Haug V, Kollar B, Tasigiorgos S, et al. Hypothermic ex situ perfusion of human limbs with acellular solution for 24 hours. Transplantation. 2020;104:e260–e270.
Mazilescu LI, Goto T, John R, et al. Combining oxygenated cold perfusion with normothermic ex vivo perfusion improves the outcome of donation after circulatory death porcine kidney transplantation. Transplantation. 2024;108:184–191.
Wei JCJ, Edwards GA, Martin DJ, et al. Allometric scaling of skin thickness, elasticity, viscoelasticity to mass for micro-medical device translation: from mice, rats, rabbits, pigs to humans. Sci Rep. 2017;7:15885.
Zhang MH. Rhabdomyolosis and its pathogenesis. World J Emerg Med. 2012;3:11–15.
Khalifian S, Raimondi G, Brandacher G. The use of Luminex assays to measure cytokines. J Invest Dermatol. 2015;135:1–5.
Turner MD, Nedjai B, Hurst T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014;1843:2563–2582.
Chaturvedi AK, Kemp TJ, Pfeiffer RM, et al. Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev. 2011;20:1902–1911.
Won JH, Goldberger O, Shen-Orr SS, et al. Significance analysis of xMap cytokine bead arrays. Proc Natl Acad Sci U S A. 2012;109:2848–2853.
Winter DA. Biomechanics and Motor Control of Human Movement. 4th ed. John Wiley and Sons; 2005.